Back to search
FDAFDA · Food and drugs·Recall number D-0546-2025

Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, India; Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-885-04

Published August 6, 2025 · Recall initiated: July 9, 2025

Summary

FDA records drug Class II recall D-0546-2025, published August 6, 2025 and initiated July 9, 2025. Recalling firm: Strides Pharma, Inc.; Status: Ongoing; Reported quantity: 6,672 bottles; Lot: Lot #: 7715893A, Exp. Date 12/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if CINACALCET has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CINACALCET
Manufacturer
Strides Pharma, Inc.
Distributor
Product was distributed nationwide within the United States
UPC
0364380885047
Lot
Lot #: 7715893A, Exp. Date 12/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, India; Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-885-04 recalled?

Yes. FDA published recall D-0546-2025 on August 6, 2025. Reported hazard: Failed Dissolution Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CINACALCET. UPC: 0364380885047.